<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Vetmedin now licensed for asymptomatic MVD in dogs</title><link>/b/veterinary-nursing-news/posts/vetmedin-now-licensed-for-asymptomatic-mvd-in-dogs</link><description> Boehringer Ingelheim has announced that Vetmedin has been granted a new licensed indication: for the treatment of asymptomatic mitral valve disease (MVD), and cardiomegaly. 
 The research on which the new indication is based is described by Boehringer</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>